Intro

This chapter explores the emerging substance 7-hydroxymitragynine (7-OH), an opioid-like compound gaining popularity in retail outlets. It examines the FDA's concerns about its abuse potential, overdose risks, and its appeal to vulnerable groups, particularly children.